A product designed for inhalation cannot be considered a dietary supplement, FDA stated in a March warning letter to Breathable Foods Inc.
A product designed for inhalation cannot be considered a dietary supplement, FDA stated in a March warning letter to Breathable Foods Inc. The agency questioned the company’s AeroShot, a mix containing caffeine and B vitamins that is described as “inhalable caffeine.”
However, wrote FDA, “By definition, dietary supplements must be intended for ingestion.”
FDA also requested additional evidence from the company to support its claims that the product, when inhaled through the lungs, is safe, as well as to support the firm’s claims that its powders are larger than 10 microns and that “[d]ecades of research have shown that particles above 10 microns in size, if inhaled, fall out in the mouth and do not penetrate the respiratory tract.”
Nutritional Outlook thanks the American Herbal Products Association for the tip.
Yili to pilot Xampla’s microscopic natural biopolymer capsules for nutrient fortification
July 17th 2024Xampla, a manufacturer natural biopolymers, has announced a partnership with Yili Innovation Centre Europe to test and validate Xampla’s microscopic natural biopolymer capsules used to fortify a range of products with vitamins and nutrients.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.